Specific inhibition of oncogenic RAS using cell-permeable RAS-binding domains
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Cell Chemical Biology
- Vol. 28 (11) , 1581-1589.e6
Abstract
No abstract availableKeywords
Funding Information
- Yasuda Memorial Medical Foundation
- Hitachi Global Foundation
- Nagoya University Hospital (A123)
- Japan Society for the Promotion of Science (19K16828)
This publication has 34 references indexed in Scilit:
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cellsNature, 2013
- In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras–effector interactionProceedings of the National Academy of Sciences, 2013
- High-resolution multi-dimensional NMR spectroscopy of proteins in human cellsNature, 2009
- Cell-penetrating peptides: A comparative membrane toxicity studyAnalytical Biochemistry, 2005
- Recognizing and Defining True Ras Binding Domains I: Biochemical AnalysisJournal of Molecular Biology, 2005
- Recognizing and Defining True Ras Binding Domains II: In Silico Prediction Based on Homology Modelling and Energy CalculationsJournal of Molecular Biology, 2005
- raf RBD and Ubiquitin Proteins Share Similar Folds, Folding Rates and Mechanisms Despite Having Unrelated Amino Acid SequencesBiochemistry, 2004
- Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migrationNature Medicine, 1998
- Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocyticallyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1998
- Two Distinct Raf Domains Mediate Interaction with RasJournal of Biological Chemistry, 1995